CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Open-market buy Director bought 2,500 shares at $7.17 ($17,925)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B7 Offering Prospectus
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 2,352 shares at $5.98 ($14,065)
- 4 Planned sale Chief Executive Officer sold 19,771 shares at $5.98 ($118,231)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 6,871 shares at $5.98 ($41,089)
- 4 Planned sale Chief Legal Officer sold 4,430 shares at $5.98 ($26,491)
Page 9 of 26 · 506 filings